Denis Olivier, Stroobant Vincent, Colau Didier, D'Souza Sushila, Huygen Kris
Laboratory of Mycobacterial Immunology, Pasteur Institute of Brussels, Engelandstraat 642, B-1180, Brussels, Belgium.
Immunol Lett. 2002 Apr 22;81(2):115-24. doi: 10.1016/s0165-2478(01)00338-8.
We previously demonstrated that Bacillus Calmette-Guerin (BCG) immunization activated D(b) restricted CD8+ cytolytic T lymphocyte (CTL) recognizing target cells incubated with mycobacterial culture filtrate. Here, we show that in vitro restimulation of spleen cells from BCG vaccinated or Mycobacterium tuberculosis infected mice with culture filtrate antigens leads to the appearance of a high percentage of D(b) restricted IFNgamma synthesizing CD8+ T cell blasts. Transporter associated protein-2 mutated RMA-S cells incubated with soluble culture filtrate proteins had their MHC class I D(b) but not K(b) molecules stabilized at the surface indicating that only D(b) ligands might be generated by antigen presenting cells. MHC class I bound peptides were acid eluted from the surface of RMA-S cells incubated with M. tuberculosis culture filtrate proteins. The crude peptide preparation was able to sensitize RMA-S cells for recognition by culture filtrate-specific cytolytic T cells. Peptides were subsequently fractionnated by reverse-phase high performance liquid chromatography and the main biological activity was identified in two fractions. These results provide a further evidence that the processing of exogenous culture filtrate proteins in vitro leads to the presentation of a restricted number or even a single immunodominant peptide to culture filtrate-specific CD8+ T cells.
我们之前证明,卡介苗(BCG)免疫可激活识别与分枝杆菌培养滤液孵育的靶细胞的D(b)限制性CD8+细胞毒性T淋巴细胞(CTL)。在此,我们表明,用培养滤液抗原对卡介苗接种或结核分枝杆菌感染小鼠的脾细胞进行体外再刺激,会导致出现高比例的D(b)限制性合成IFNγ的CD8+ T细胞母细胞。与可溶性培养滤液蛋白孵育的转运相关蛋白-2突变的RMA-S细胞,其MHC I类D(b)分子而非K(b)分子在表面稳定,这表明抗原呈递细胞可能仅产生D(b)配体。从与结核分枝杆菌培养滤液蛋白孵育的RMA-S细胞表面酸洗脱MHC I类结合肽。粗肽制剂能够使RMA-S细胞对培养滤液特异性细胞毒性T细胞的识别敏感。随后通过反相高效液相色谱法对肽进行分级分离,并在两个级分中鉴定出主要生物活性。这些结果进一步证明,体外处理外源性培养滤液蛋白会导致向培养滤液特异性CD8+ T细胞呈递数量有限甚至单一的免疫显性肽。